Rhineton Syrup 5 ml Syrup
PDF Leaflet Revision Date: 10 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of conditions responsive to antihistaminic therapy.
Dosage (summary)
Adults: 5-20 ml daily in divided doses.
Onset of Action / Duration
Onset: 2-3 hours, Duration: 4-6 hours
Special Populations
- Geriatrics
- Diabetes mellitus
- Epilepsy
- Bladder neck obstruction
- Prostatic hypertrophy
Pregnancy & Breastfeeding
Not recommended in early pregnancy; avoid in breastfeeding due to potential infant irritability.
Key Drug Interactions
- CNS depressants
- Alcohol
- Antimuscarinic drugs
Contraindications
- Neonates
- Lactation
- Epilepsy
- Acute asthma attacks
Common side effects
- Drowsiness
- Dizziness
- Nausea
- Dry mouth
- Blurred vision
Counselling Points
- Avoid alcohol and CNS depressants
- Do not operate machinery if drowsy
- Monitor for unusual excitement in children
Serious warnings
- May impair ability to drive
- Risk of drowsiness
- Caution in geriatric patients
Important Disclaimer
The Rhineton Syrup 5 ml Syrup professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
